资讯

Targeted Oncology1 小时
FDA Clears Oncomine Dx Express Test for Sunvozertinib in EGFR Exon 20+ NSCLC
The FDA approves a rapid test for identifying patients with NSCLC eligible for sunvozertinib, enhancing timely, precision ...
Investing Snacks9 小时
FDA Clears Thermo Fisher’s Rapid Cancer Test
Thermo Fisher Scientific secured FDA approval for its Oncomine Dx Express Test, marking a leap forward in cancer diagnostics.